GeneTex

  • Country / Location Selection

United States (US)

SMN1/SMN2 blocking peptide

Cat. No. GTX89136-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89136.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-DESENSRSPGNKSDN

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

BCD541 blocking peptide , SMA@ blocking peptide , SMA3 blocking peptide , TDRD16A blocking peptide , SMA blocking peptide , SMA4 blocking peptide , GEMIN1 blocking peptide , SMN blocking peptide , T BCD541 blocking peptide , SMN1 blocking peptide , SMA2 blocking peptide , SMNT blocking peptide , SMA1 blocking peptide

Background

This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The telomeric and centromeric copies of this gene are nearly identical and encode the same protein. However, mutations in this gene, the telomeric copy, are associated with spinal muscular atrophy; mutations in the centromeric copy do not lead to disease. The centromeric copy may be a modifier of disease caused by mutation in the telomeric copy. The critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer. Note that the nine exons of both the telomeric and centromeric copies are designated historically as exon 1, 2a, 2b, and 3-8. It is thought that gene conversion events may involve t

Research Area

REFERENCE

There are currently no references for SMN1/SMN2 blocking peptide (GTX89136-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for SMN1/SMN2 blocking peptide (GTX89136-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239